Yin Dou - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Yin Dou

Showing results (21-30 of 26) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 26 results.

Biomaterials|April 18, 2013

Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxelHongmei He, Sha Chen, Jianzhi Zhou, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|May 29, 2016

Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in miceYin Dou, Jiawei Guo, Yue Chen, et al.

Acta Pharmaceutica Sinica. B|November 28, 2025

Orally deliverable biomimetic nucleic acid therapies for targeted treatment of atherosclerosisChenwen Li, Yidan Chen, Yuan Li, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2023

Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapyKaijian Ling, Yin Dou, Neng Yang, et al.

Nano Letters|January 12, 2017

Yeast Microcapsule-Mediated Targeted Delivery of Diverse Nanoparticles for Imaging and Therapy via the Oral RouteXing Zhou, Xiangjun Zhang, Songling Han, et al.

Acta Pharmaceutica Sinica. B|February 23, 2023

Pathologically triggered <i>in situ</i> aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiationQiang Nie, Chenwen Li, Yu Wang, et al.

Pageof 3

Search research articles

Showing results (21-30 of 26) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 26 results.

Biomaterials|April 18, 2013

Cyclodextrin-derived pH-responsive nanoparticles for delivery of paclitaxelHongmei He, Sha Chen, Jianzhi Zhou, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|May 29, 2016

Sustained delivery by a cyclodextrin material-based nanocarrier potentiates antiatherosclerotic activity of rapamycin via selectively inhibiting mTORC1 in miceYin Dou, Jiawei Guo, Yue Chen, et al.

Acta Pharmaceutica Sinica. B|November 28, 2025

Orally deliverable biomimetic nucleic acid therapies for targeted treatment of atherosclerosisChenwen Li, Yidan Chen, Yuan Li, et al.

Journal of Controlled Release : Official Journal of the Controlled Release Society|July 9, 2023

Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapyKaijian Ling, Yin Dou, Neng Yang, et al.

Nano Letters|January 12, 2017

Yeast Microcapsule-Mediated Targeted Delivery of Diverse Nanoparticles for Imaging and Therapy via the Oral RouteXing Zhou, Xiangjun Zhang, Songling Han, et al.

Acta Pharmaceutica Sinica. B|February 23, 2023

Pathologically triggered <i>in situ</i> aggregation of nanoparticles for inflammation-targeting amplification and therapeutic potentiationQiang Nie, Chenwen Li, Yu Wang, et al.

Pageof 3